Pro-Dex (PDEX) Competitors $32.00 -1.33 (-3.99%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$32.08 +0.08 (+0.23%) As of 02/21/2025 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends PDEX vs. SMLR, TCMD, NNOX, NPCE, CVRX, ZIMV, NYXH, SMTI, AVR, and RCELShould you be buying Pro-Dex stock or one of its competitors? The main competitors of Pro-Dex include Semler Scientific (SMLR), Tactile Systems Technology (TCMD), Nano-X Imaging (NNOX), NeuroPace (NPCE), CVRx (CVRX), ZimVie (ZIMV), Nyxoah (NYXH), Sanara MedTech (SMTI), Anteris Technologies Global (AVR), and AVITA Medical (RCEL). These companies are all part of the "medical equipment" industry. Pro-Dex vs. Semler Scientific Tactile Systems Technology Nano-X Imaging NeuroPace CVRx ZimVie Nyxoah Sanara MedTech Anteris Technologies Global AVITA Medical Semler Scientific (NASDAQ:SMLR) and Pro-Dex (NASDAQ:PDEX) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, community ranking, valuation, analyst recommendations, media sentiment, institutional ownership, earnings, dividends and profitability. Which has more risk & volatility, SMLR or PDEX? Semler Scientific has a beta of 1.17, indicating that its share price is 17% more volatile than the S&P 500. Comparatively, Pro-Dex has a beta of 0.53, indicating that its share price is 47% less volatile than the S&P 500. Do analysts rate SMLR or PDEX? Semler Scientific currently has a consensus price target of $71.00, indicating a potential upside of 48.72%. Pro-Dex has a consensus price target of $52.00, indicating a potential upside of 62.50%. Given Pro-Dex's higher probable upside, analysts clearly believe Pro-Dex is more favorable than Semler Scientific.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Semler Scientific 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Pro-Dex 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable earnings and valuation, SMLR or PDEX? Semler Scientific has higher revenue and earnings than Pro-Dex. Semler Scientific is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSemler Scientific$56.29M7.86$20.58M$4.919.72Pro-Dex$53.84M1.94$2.13M$2.0115.92 Do insiders and institutionals have more ownership in SMLR or PDEX? 49.4% of Semler Scientific shares are held by institutional investors. Comparatively, 15.3% of Pro-Dex shares are held by institutional investors. 30.2% of Semler Scientific shares are held by company insiders. Comparatively, 47.5% of Pro-Dex shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the MarketBeat Community prefer SMLR or PDEX? Pro-Dex received 153 more outperform votes than Semler Scientific when rated by MarketBeat users. However, 66.67% of users gave Semler Scientific an outperform vote while only 62.00% of users gave Pro-Dex an outperform vote. CompanyUnderperformOutperformSemler ScientificOutperform Votes266.67% Underperform Votes133.33% Pro-DexOutperform Votes15562.00% Underperform Votes9538.00% Does the media prefer SMLR or PDEX? In the previous week, Semler Scientific had 8 more articles in the media than Pro-Dex. MarketBeat recorded 8 mentions for Semler Scientific and 0 mentions for Pro-Dex. Pro-Dex's average media sentiment score of 0.75 beat Semler Scientific's score of 0.65 indicating that Pro-Dex is being referred to more favorably in the news media. Company Overall Sentiment Semler Scientific Positive Pro-Dex Positive Is SMLR or PDEX more profitable? Semler Scientific has a net margin of 72.65% compared to Pro-Dex's net margin of 11.06%. Semler Scientific's return on equity of 50.77% beat Pro-Dex's return on equity.Company Net Margins Return on Equity Return on Assets Semler Scientific72.65% 50.77% 47.04% Pro-Dex 11.06%21.68%12.40% SummarySemler Scientific beats Pro-Dex on 11 of the 16 factors compared between the two stocks. Get Pro-Dex News Delivered to You Automatically Sign up to receive the latest news and ratings for PDEX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PDEX vs. The Competition Export to ExcelMetricPro-DexSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$108.69M$4.61B$5.81B$9.02BDividend YieldN/A39.91%4.77%3.84%P/E Ratio15.9224.1021.5016.68Price / Sales1.9450.59453.1985.13Price / Cash34.8151.2243.9637.32Price / Book3.286.577.654.65Net Income$2.13M$90.13M$3.18B$245.69M7 Day Performance-9.66%-2.20%-1.95%-2.67%1 Month Performance-23.17%-2.17%-0.23%-2.16%1 Year Performance87.03%15.26%16.69%12.90% Pro-Dex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PDEXPro-Dex3.752 of 5 stars$32.00-4.0%$52.00+62.5%+81.8%$108.69M$53.84M15.92140SMLRSemler Scientific3.0876 of 5 stars$49.67+0.4%$71.00+42.9%+3.7%$460.44M$68.18M24.23120Earnings ReportTCMDTactile Systems Technology2.7195 of 5 stars$17.33+2.3%$23.00+32.7%+8.4%$415.92M$274.42M26.66980Earnings ReportAnalyst DowngradeAnalyst RevisionNews CoverageNNOXNano-X Imaging1.9514 of 5 stars$6.72-11.0%$17.50+160.4%-31.8%$388.28M$9.90M-7.91190High Trading VolumeNPCENeuroPace2.2029 of 5 stars$12.31+1.8%$14.80+20.2%-11.8%$367.43M$76.45M-12.31170Insider TradeNews CoverageHigh Trading VolumeCVRXCVRx2.783 of 5 stars$15.09+4.1%$17.83+18.2%-36.8%$366.14M$51.29M-5.61160ZIMVZimVie1.8623 of 5 stars$13.14-0.2%$19.50+48.4%-29.8%$362.65M$451.29M-1.002,600Upcoming EarningsNYXHNyxoah2.8546 of 5 stars$10.53-0.4%$17.00+61.4%-32.1%$358.65M$5.08M-5.63110High Trading VolumeSMTISanara MedTech2.1665 of 5 stars$35.02-0.7%$47.00+34.2%-10.3%$306.08M$64.99M-35.3760AVRAnteris Technologies GlobalN/A$7.99+1.9%$16.50+106.5%N/A$287.16MN/A0.00138RCELAVITA Medical1.5394 of 5 stars$10.57+20.4%$18.00+70.3%-44.0%$277.15M$50.14M-4.74130Upcoming EarningsAnalyst ForecastInsider TradeNews CoverageGap UpHigh Trading Volume Related Companies and Tools Related Companies SMLR Competitors TCMD Competitors NNOX Competitors NPCE Competitors CVRX Competitors ZIMV Competitors NYXH Competitors SMTI Competitors AVR Competitors RCEL Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PDEX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pro-Dex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pro-Dex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.